Searchable abstracts of presentations at key conferences in endocrinology

ea0036P56 | (1) | BSPED2014

Low birth weight is not a feature of polycystic ovarian syndrome in a British cohort of adolescents, but obesity and metabolic syndrome are common associations

Frerichs Carley , Das Urmi , Dharmaraj Poonam , Didi Mohammed , Hernon Mary , Ramikrishnan Renuka , Blair Jo

Background: Adolescent polycystic ovarian syndrome (PCOS) is being diagnosed more frequently as the prevalence of childhood obesity increases. Adolescent PCOS has been associated with low birth weight (LBW), exaggerated adrenarche (EA) and metabolic syndrome in Mediterranean populations. This study describes the clinical phenotype of a cohort of northern European girls.Methods: A retrospective study of adolescents with PCOS, diagnosed according to the Ro...

ea0058p004 | Adrenal | BSPED2018

Adrenocortical function in infants admitted to PICU

Pintus Donatella , Das Urmi , Dharmaraj Poonam , Didi Mohammed , Ramakrishnan Renuka , Senniappan Senthil , Thorburn Keith , Blair Joanne

Background: Hypocortisolaemia is common in neonates1 and infants following cardiac surgery.2 In critically ill children with other pathologies, hypocortisolaemia may result from accelerated cortisol metabolism and reduced protein binding. However, the timing and frequency of normalisation of cortisol concentrations following infantile critical illness is poorly described.Objective: To describe the natural history of hypocortisolaemi...

ea0070aep1027 | Hot topics (including COVID-19) | ECE2020

Utilising internet of things and artificial intelligence to enable twin precision treatment for reversal of type 2 Diabetes

Shamanna Paramesh , Damodharan Suresh , Saboo Banshi , Chawla Rajeev , Mohammed Jahangir , Mohamed Maluk , Thajudeen Mohamad

Introduction: We evaluated Twin Precision Treatment (TPT) approach, a cluster of Internet of Things (IoT) and Artificial Intelligence (AI), validated biosensors and Continuous Glucose Monitoring (CGM) through Ambulatory Glucose Profile (AGP) integrated with machine learning algorithms, enabling physicians to empower patients to reverse diabetes.Methods: 64 T2DM (19 males, 45 female), registered on Twin Health TM service, managed by standard care of appro...

ea0070ep149 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Vitamin D deficiency in children and adolescents with type 1 diabetes mellitus

Lazreg Youssef , Mohammed Aymane Loukili , Cheikh Sidi Ahmed Ould , Sihame Rouf , Hanane Latrech

Introduction: Besides its role in calcium homeostasis, vitamin D (VD) has an important immune mudulation effect. However, its role in autoimmune diseases such as type 1 diabetes is under discussion. In this study, we aimed to assess VD status in children and adolescents with type 1 diabetes mellitus (T1DM).Material and Methods: This is a retrospective descriptive study realized at the endocrinology–diabetology department of OUJDA’s Mohammed V...

ea0070ep310 | Pituitary and Neuroendocrinology | ECE2020

Familial X-linked kallman syndrome associated with ptosis, case series

Elamin Yasir , Hussain Al-Qahtani Mohammad , Mohammed Alabdrabalnabi Fatimah , Abdulwahed Al Saeed Zahra

Kallmann syndrome is a rare congenital hypogonadotropic hypogonadism with variable degrees of hyposomia to anosmia. This syndrome can be transmitted as autosomal dominant, autosomal recessive and X-linked inheritance pattern. We are reporting two cases of young male siblings (17 and 16 years old) who are the offspring of unrelated parents, presenting with delayed puberty and both were complaining of hyposmia. Their older brother, aged 24 years, was diagnosed with isolated hypo...

ea0033oc2.10 | Oral Communications 2 | BSPED2013

A new approach to the definition and diagnosis of adrenal insufficiency during inhaled corticosteroid therapy for asthma

Blair Jo , Didi Mohammed , Lancaster Gillian , Titman Andrew , Newland Paul , Collingwood Catherine , Peak Matthew , Couriel Jonathon

Background: Up to 50% of children treated with inhaled corticosteroids (ICS) have biochemical evidence of adrenal insufficiency (AI). Episodes of adrenal crisis (AC) are extremely rare.To address the discordance between the prevalence of biochemical AI and AC, we re-examined the biochemical definition of AI during ICS therapy. We then investigated the utility of early morning salivary cortisol (EMSC) and cortisone (EMSCn) for the identification of patien...

ea0031p209 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

The endocrine and metabolic characteristics of a large Bardet–Biedl syndrome clinic population

Mujahid Safa , Huda Mohammed , Forsythe Elizabeth , Hazlehurst Jonathan , Tomlinson Jeremy , Beales Philip , Carroll Paul , McGowan Barbara

Background: Bardet Biedl syndrome (BBS) is a rare autosomal recessive disorder caused by ciliary dysfunction. It is characterised by rod cone dystrophy, polydactyly, renal dysfunction, cognitive impairment. Endocrine consequences are thought to include hypogonadism, obesity and polyuria. However little is known about the endocrine and metabolic abnormalities in adult patients.Methods: One hundred and fifty-four patients with BBS were identified through t...

ea0028p149 | Neoplasia, cancer and late effects | SFEBES2012

Use of Vandetenib in metastatic medullary carcinoma of thyroid in a paediatric patient with Multiple Endocrine Neoplasia (MEN)2B

Narayanan Vidya , Bradshaw Nicola , Davidson Rosemarie , Welbury Richard , Macgregor Fiona , Ronghe Milind , Reed Nick , Shaikh Mohammed

Vandetenib has been used as novel treatment of locally invasive medullary carcinoma of thyroid. We report the use of Vandetenib in a paediatric patient with inoperable medullary carcinoma of thyroid gland. Our patient presented to the dental surgeons at age 12 years with tongue and lip swellings. Biopsy demonstrated mucosal neuromas suggestive of MEN2B. He was clinically euthyroid but had a firm goitre. Ultrasound showed a large heterogenous thyroid mass encasing the common ca...

ea0028p193 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Annexin A1, an anti-inflammatory regulator, is expressed in human adipocytes

Kosicka-Knox Anna , Cunliffe Adam , Mackenzie Richard , Zariwala Mohammed , Renshaw Derek

Annexin A1 (AnxA1), an endogenous glucocorticoid regulated protein, is a pivotal homeostatic regulator of the magnitude of the inflammatory response. We have previously demonstrated that plasma AnxA1 protein is significantly inversely correlated with waist to hip ratio (P=0.017). Given that low-level systemic inflammation is seen in metabolic syndrome-associated chronic pathologies, here, we investigate if AnxA1 is also involved in the regulation of adipose tissue infla...

ea0028p229 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

A putative role for amino acids in appetite regulation

McGavigan Anne , Greenwood Hannah , Kinsey-Jones James , Ghatei Mohammed , Bloom Stephen , Murphy Kevin

Obesity is a major worldwide health problem with limited treatment options. Recent research has highlighted the importance of gastrointestinal (GI) nutrient sensing in the regulation of food intake and metabolism. Protein as a macronutrient induces the strongest feeling of satiety per calorie. However, different types of protein have varying effects on appetite, suggesting protein induced satiety may be due to the specific amino acids generated by protein digestion. We have id...